[go: up one dir, main page]

AU2001273052A1 - Antifungal compounds and methods of use - Google Patents

Antifungal compounds and methods of use

Info

Publication number
AU2001273052A1
AU2001273052A1 AU2001273052A AU7305201A AU2001273052A1 AU 2001273052 A1 AU2001273052 A1 AU 2001273052A1 AU 2001273052 A AU2001273052 A AU 2001273052A AU 7305201 A AU7305201 A AU 7305201A AU 2001273052 A1 AU2001273052 A1 AU 2001273052A1
Authority
AU
Australia
Prior art keywords
methods
antifungal compounds
antifungal
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273052A
Inventor
Ed T. Buurman
Eugene Davidov
Thamare Desilva
Tariq Haq
Sandra Harris
Svetlana Komarnitsky
Fan Long
Melissa Mccoy
Marc Mendillo
Daniel Moore
Jeffrey Moore
Karen Sanderson
Craig M. Thompson
Shuhao Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anadys Pharmaceuticals Inc
Original Assignee
Anadys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals Inc filed Critical Anadys Pharmaceuticals Inc
Publication of AU2001273052A1 publication Critical patent/AU2001273052A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001273052A 2000-06-29 2001-06-28 Antifungal compounds and methods of use Abandoned AU2001273052A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21516400P 2000-06-29 2000-06-29
US60/215,164 2000-06-29
US22445700P 2000-08-10 2000-08-10
US60/224,457 2000-08-10
PCT/US2001/020592 WO2002002055A2 (en) 2000-06-29 2001-06-28 Antifungal compounds and methods of use

Publications (1)

Publication Number Publication Date
AU2001273052A1 true AU2001273052A1 (en) 2002-01-14

Family

ID=26909770

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273052A Abandoned AU2001273052A1 (en) 2000-06-29 2001-06-28 Antifungal compounds and methods of use

Country Status (6)

Country Link
US (1) US20030027243A1 (en)
EP (1) EP1385981A2 (en)
JP (1) JP2004511756A (en)
AU (1) AU2001273052A1 (en)
CA (1) CA2413753A1 (en)
WO (1) WO2002002055A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002010217A2 (en) 2000-08-02 2002-02-07 The Johns Hopkins University Endothelial cell expression patterns
US7420030B2 (en) 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US7452964B2 (en) 2001-09-07 2008-11-18 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides against placenta and adipose tissues
US20040170955A1 (en) 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
CA2487077A1 (en) * 2002-06-10 2003-12-18 Merck & Co., Inc. Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof
WO2004076682A2 (en) * 2003-02-26 2004-09-10 Surromed, Inc. Targets for controlling cellular growth and for diagnostic methods
US20050187161A1 (en) * 2003-09-12 2005-08-25 Board Of Regents, The University Of Texas System Biopanning as an approach to study the pathogenesis of and produce novel treatment modalities for invasive Aspergillosis
JP5041231B2 (en) * 2005-02-15 2012-10-03 東亞合成株式会社 Antibacterial peptides and their use
WO2012178036A2 (en) * 2011-06-22 2012-12-27 Mayo Foundation For Medical Education And Research Inhibitors of rtt109 as anti-fungal agents
JP2019068843A (en) * 2018-12-28 2019-05-09 ダンスター・フェルメント・アーゲー Yeast cell wall containing vitamin d2, use of the same, and method for producing the same
JP7345122B2 (en) * 2019-07-04 2023-09-15 国立大学法人 東京大学 Screening method for antifungal agents and antifungal agents that are inhibitors of fungal pathogenicity expression
JP7359366B2 (en) * 2019-07-04 2023-10-11 学校法人帝京大学 Antifungal agent screening method
CN112695078A (en) * 2021-02-05 2021-04-23 杭州医学院 Method for screening hyphal Candida albicans virulence related gene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641627A (en) * 1993-10-25 1997-06-24 Ribogene, Inc. Methods for screening for antimycotics
US6280963B1 (en) * 1997-11-07 2001-08-28 Millennium Pharmaceuticals, Inc. Essential fungal genes and their use
CA2218446A1 (en) * 1997-12-12 1999-06-12 Mcgill University New candida albicans kre9 and uses thereof

Also Published As

Publication number Publication date
JP2004511756A (en) 2004-04-15
US20030027243A1 (en) 2003-02-06
CA2413753A1 (en) 2002-01-10
EP1385981A2 (en) 2004-02-04
WO2002002055A2 (en) 2002-01-10
WO2002002055A3 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
AUPR001000A0 (en) Novel chemical compounds and their use
AU2001280599A1 (en) Compounds and methods
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001253418A1 (en) Compounds and methods
AU2001251358A1 (en) Prion-binding ligands and methods of using same
AU2002314466A1 (en) Withasol and methods of use
AU2001277526A1 (en) Substituted benzo-nitro-heterocycles and use thereof as herbicides
AU2001216218A1 (en) Heterocyclic analgesic compounds and method of use thereof
AU2001288972A1 (en) Antipsychotic sulfonamide-heterocycles, and methods of use thereof
AU2001243394A1 (en) Compounds and methods
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2001273052A1 (en) Antifungal compounds and methods of use
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AUPQ872300A0 (en) Compounds and methods
AU2001238152A1 (en) Insecticidal compounds and methods for selection thereof
AU2001239246A1 (en) Novel use of herbicides
AU2002359694A1 (en) Compounds and methods
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2001278951A1 (en) Compounds and methods
AU2001264273A1 (en) Amide compounds and use thereof
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU4432001A (en) Trityl-type compounds and their use
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use